CASP3 and hepatocellular carcinoma: Furthermore, a caspase-3 activity assay revealed that there were markedly reduced IMB-6G-induced caspase-3 activity in IRE1α or PERK knocked down HCC cells (Figure 5D), which is consistent with its decline of IMB-6G-induced apoptosis (Figure 5C).